Prosecution Insights
Prosecution Insights
28 pending office actions • 6 clients • 27 examiners • 22 art units • 0 of 28 (0%) have an AI response strategy ready • 29 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (4%) |
| §103 only | 13 (46%) |
| §102 only | 2 (7%) |
| §112 only | 5 (18%) |
| Double-patenting only | 6 (21%) |
| No statute on record | 1 (4%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SANG, HONG | 2 | 54.8% | +62.2% |
| MONTGOMERY, ANN Y | 1 | 69.4% | +27.1% |
| SHIM, DAVID M. | 1 | 58.0% | +55.9% |
| JACKSON-TONGUE, LAKIA J | 1 | 68.9% | +20.6% |
| BURKHART, MICHAEL D | 1 | 62.5% | +11.1% |
| BELYAVSKYI, MICHAIL A | 1 | 64.0% | +27.5% |
| LANDSMAN, ROBERT S | 1 | 81.4% | +13.1% |
| HADDAD, MAHER M | 1 | 50.5% | +54.3% |
| WEBB, WALTER E | 1 | 46.5% | +18.6% |
| BRADLEY, CHRISTINA | 1 | 62.8% | +33.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18282919 | BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF | LANDSMAN, ROBERT S | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17620248 | INTERLEUKIN-27 PRODUCING B-CELLS AND USES THEREOF | THUESON, HANNA MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18722188 | METHODS AND SYSTEMS FOR ANALYZING TARGET ENGAGEMENT DATA FROM BIOLOGICAL ASSAYS | MONTGOMERY, ANN Y | 30d overdue |
| 18037379 | TYROSYL-LOCK PEPTIDES | BRADLEY, CHRISTINA | 4d overdue |
| 18271583 | EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF | WEBB, WALTER E | 76d |
| 18735506 | FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS | SHIM, DAVID M. | — |
| 18664031 | BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE | JACKSON-TONGUE, LAKIA J | — |
| 18644724 | BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES | BURKHART, MICHAEL D | — |
| 18583139 | T CELL RECEPTORS RECOGNIZING MUTATED P53 | BELYAVSKYI, MICHAIL A | — |
| 18502993 | M971 CHIMERIC ANTIGEN RECEPTORS | SANG, HONG | — |
| Art Unit | Apps |
|---|---|
| 1638 | 3 |
| 1612 | 2 |
| 1632 | 2 |
| 1678 | 1 |
| 1626 | 1 |
| 1645 | 1 |
| 1644 | 1 |
| 1646 | 1 |
| 1647 | 1 |
| 1641 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18722188 | METHODS AND SYSTEMS FOR ANALYZING TARGET ENGAGEMENT DATA FROM BIOLOGICAL ASSAYS | The United States Department of Health and Human Services | MONTGOMERY, ANN Y | 1678 | §112 | Non-Final OA | 30d overdue | Pending | Jun 20, 2024 |
| 18735506 | FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS | Northwestern University | SHIM, DAVID M. | 1626 | §103 | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18664031 | BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE | The United States Department of Health and Human Services | JACKSON-TONGUE, LAKIA J | 1645 | DP | Non-Final OA | — | Pending | May 14, 2024 |
| 18644724 | BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES | The United States Department of Health and Human Services | BURKHART, MICHAEL D | DP | Non-Final OA | — | Pending | Apr 24, 2024 | |
| 18583139 | T CELL RECEPTORS RECOGNIZING MUTATED P53 | The United States Department of Health and Human Services | BELYAVSKYI, MICHAIL A | 1644 | Other | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18502993 | M971 CHIMERIC ANTIGEN RECEPTORS | The United States Department of Health and Human Services | SANG, HONG | 1646 | DP | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18503107 | M971 CHIMERIC ANTIGEN RECEPTORS | The United States Department of Health and Human Services | SANG, HONG | DP | Non-Final OA | — | Pending | Nov 06, 2023 | |
| 18282919 | BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF | The United States Department of Health and Human Services | LANDSMAN, ROBERT S | 1647 | §103 | Non-Final OA | — | Pending | Sep 19, 2023 |
| 18277521 | HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22 | The United States Department of Health and Human Services | HADDAD, MAHER M | 1641 | §112 | Non-Final OA | — | Pending | Aug 16, 2023 |
| 18271583 | EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF | The United States Department of Health and Human Services | WEBB, WALTER E | 1612 | §103 | Non-Final OA | 76d | Pending | Jul 10, 2023 |
| 18037379 | TYROSYL-LOCK PEPTIDES | The University of Queensland | BRADLEY, CHRISTINA | 1654 | §112 | Non-Final OA | 4d overdue | Pending | May 17, 2023 |
| 18028463 | PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER | The United States Department of Health and Human Services | HERNANDEZ, JACKSON J | 1627 | §102 | Final Rejection | — | Pending | Mar 24, 2023 |
| 18026421 | NOVEL ADENO-ASSOCIATED VIRAL (AAV) VECTORS TO TREAT HEREDITARY METHYLMALONIC ACIDEMIA (MMA) CAUSED BY METHYLMALONYL-COA MUTASE (MMUT) DEFICIENCY | The United States Department of Health and Human Services | ARMATO JR, DENNIS IGNATIUS | 1651 | DP | Final Rejection | — | Pending | Mar 15, 2023 |
| 17910911 | SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES | The United States Department of Health and Human Services | HOBBS, MICHAEL L | 1799 | §103 | Non-Final OA | 6d | Pending | Feb 15, 2023 |
| 18147786 | METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION | The United States Of America, A Represented By The Secretary, Department Of Health And Human Servi | CORDAS, EMILY ANN | 1632 | §103 | Final Rejection | — | Pending | Dec 29, 2022 |
| 18012056 | HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD20 | The United States Department of Health and Human Services | WEIDNER, ADAM M | 1675 | §112 | Non-Final OA | — | Pending | Dec 21, 2022 |
| 18056356 | GENE THERAPY FOR COMBINED METHYLMALONIC ACIDEMIA/ACIDURIA AND HYPERHOMOCYSTEINEMIA/HOMOCYSTINURIA, COBALAMIN C TYPE, AND DEFICIENCY OF MMACHC | The United States Department of Health and Human Services | SHIN, DANA H | 1635 | §112 | Final Rejection | 78d | Pending | Nov 17, 2022 |
| 17918725 | THYCLOTIDES | The United States Department of Health and Human Services | GALSTER, SAMUEL LEONARD | 1693 | §103 | Non-Final OA | — | Pending | Oct 13, 2022 |
| 17912315 | METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY | The United States Department of Health and Human Services | BUNKER, AMY M | 1684 | §103 | Final Rejection | — | Pending | Sep 16, 2022 |
| 17793753 | HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS) | The United States Department of Health and Human Services | HOLLAND, PAUL J | 1656 | §103 | Final Rejection | — | Pending | Jul 19, 2022 |
| 17790939 | METHODS OF PRODUCING T CELL POPULATIONS USING INDUCED PLURIPOTENT STEM CELLS | The United States Department of Health and Human Services | TAKENAKA, RISA | 1632 | §103 | Non-Final OA | — | Pending | Jul 05, 2022 |
| 17557845 | CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 | The United States Department of Health and Human Services | HILL, KEVIN KAI | 1638 | DP | Final Rejection | — | Pending | Dec 21, 2021 |
| 17620248 | INTERLEUKIN-27 PRODUCING B-CELLS AND USES THEREOF | The United States Department of Health and Human Services | THUESON, HANNA MARIE | 1638 | §101 | Final Rejection | — | Pending | Dec 17, 2021 |
| 17430891 | HANDGRIP RELAXOMETER SYSTEM | The United States Department of Health and Human Services | MARMOR II, CHARLES ALAN | 3791 | §103 | Final Rejection | — | Pending | Aug 13, 2021 |
| 17429391 | GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES | The United States Department of Health and Human Services | ROGERS, ERIC JASON | 1638 | §103 | Final Rejection | 50d overdue | Pending | Aug 09, 2021 |
| 16980205 | ANTI-CD33 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES | The United States Department of Health and Human Services | EDGINGTONGIORDANO, FRANCESCA | 1643 | §103 | Non-Final OA | — | Pending | Sep 11, 2020 |
| 16977897 | POSITIVE ALLOSTERIC MODULATORS OF DOPAMINE 1 RECEPTOR AND METHOD OF USE THEREOF | The University of North Carolina at Chapel Hill | OTTON, ALICIA L | 1699 | §102 | Final Rejection | — | Pending | Sep 03, 2020 |
| 16758009 | ISOTOPIC BIOMARKERS OF ORGANIC ACIDEMIAS | The United States Department of Health and Human Services | COHEN, MICHAEL P | 1612 | §103 | Final Rejection | — | Pending | Apr 21, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial